Elissa S. Cote - Jun 23, 2025 Form 3 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Corp Development Officer
Signature
/s/ Elissa S. Cote
Stock symbol
VTGN
Transactions as of
Jun 23, 2025
Transactions value $
$0
Form type
3
Date filed
6/25/2025, 05:15 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cote Elissa S. Chief Corp Development Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Elissa S. Cote 2025-06-25 0002069951

No securities are beneficially owned.